FDA is lax on drug trial oversight, report says (MSNBC)

Missing information, loopholes and weak oversight hamper efforts to uncover financial conflicts by researchers who test experimental drugs before companies seek U.S. government approval, an internal watchdog finds.

Original post: 
FDA is lax on drug trial oversight, report says (MSNBC)